CAS 2761021-80-9

Fórmula: C35H36F4N6O7S

InChI: InChI=1S/C28H28F4N6O4.C7H8O3S/c1-37-9-7-16(8-10-37)34-24(39)17-11-22(41-3)20(12-19(17)29)35-27-33-13-18(28(30,31)32)25(36-27)42-21-6-4-5-15-14-38(2)26(40)23(15)21;1-6-2-4-7(5-3-6)11(8,9)10/h4-6,11-13,16H,7-10,14H2,1-3H3,(H,34,39)(H,33,35,36);2-5H,1H3,(H,8,9,10)

Chave InChI: LOKCCATVJFYTFP-UHFFFAOYSA-N

SMILES: CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCC(CC1)NC(=O)C2=CC(=C(C=C2F)NC3=NC=C(C(=N3)OC4=CC=CC5=C4C(=O)N(C5)C)C(F)(F)F)OC

Ifebemtinib tosylate

CAS: 2761021-80-9

Ifebemtinib (tosylate) (BI-853520 (tosylate); IN-10018 (tosylate)) is a highly selective PTK2 kinase inhibitor with anti-tumor properties. It inhibits FAK autophosphorylation in prostate cancer cells and suppresses spheroid formation and in situ tumor growth in vivo. Ifebemtinib (tosylate) is applicable in cancer research, including studies on solid tumors, breast cancer, and malignant pleural mesothelioma.

Fórmula: C₃₅H₃₆F₄N₆O₇S

Cor e Forma: Solid

Peso molecular: 760.76

Ref: TM-T211841